(Q40522300)
Statements
Pre-clinical immunogenicity and anti-tumour efficacy of a deleted recombinant human papillomavirus type 16 E7 protein (English)
Sophie Hallez
Jean-Marc Brulet
Caroline Vandooren
Frédéric Maudoux
Séverine Thomas
Michel Heinderickx
Alex Bollen
Ruddy Wattiez